General Information
Drug ID
DR01287
Drug Name
Ortataxel
Synonyms
Hexanoic acid; 13-(N-tert-butoxycarbonyl-beta-isobutyisoserinyl)-14-hydroxy-baccatin-1,14-carbonate; 13-(N-tert-butoxycarbonyl-beta-isobutyisoserinyl)-14-hydroxybaccatin-1,14-carbonate; 186348-23-2; 8H61Y4E29N; BAY-59; Bay-59-8862; CHEMBL382300; DB11669; Genz29155; Hexanoic acid, 3-(((1,1-dimethylethoxy)carbonyl)amino)-2-hydroxy-5-methyl-,; IDN 5109; IDN-5109; IND-5109; IND5109; Ortataxel [INN]; SB-T 101131; SB-T-101131; SCHEMBL9932772; UNII-8H61Y4E29N; Z-3102; idn5109
Drug Type
Small molecular drug
Indication Lung cancer [ICD11: 2C25] Phase 2 [1]
Kidney cancer [ICD11: 2C90-2C91] Phase 2 [1]
Glioblastoma [ICD11: 2A00.0] Phase 2 [1]
Structure
3D MOL 2D MOL
Formula
C44H57NO17
Canonical SMILES
CC1=C2C(C(=O)C3(C(CC4C(C3C(C5(C2(C)C)C(C1OC(=O)C(C(CC(C)C)NC(=O)OC(C)(C)C)O)OC(=O)O5)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)OC(=O)C
InChI
InChI=1S/C44H57NO17/c1-20(2)17-25(45-38(53)61-40(6,7)8)29(49)37(52)57-30-21(3)28-31(56-22(4)46)33(50)42(11)26(48)18-27-43(19-55-27,60-23(5)47)32(42)35(58-36(51)24-15-13-12-14-16-24)44(41(28,9)10)34(30)59-39(54)62-44/h12-16,20,25-27,29-32,34-35,48-49H,17-19H2,1-11H3,(H,45,53)/t25-,26-,27+,29+,30+,31+,32-,34-,35-,42+,43-,44+/m0/s1
InChIKey
BWKDAMBGCPRVPI-ZQRPHVBESA-N
CAS Number
CAS 186348-23-2
Pharmaceutical Properties Molecular Weight 871.9 Topological Polar Surface Area 246
Heavy Atom Count 62 Rotatable Bond Count 16
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 17
XLogP
3.7
PubChem CID
6918412
PubChem SID
12015217 , 14914125 , 14914126 , 17194875 , 43529782 , 50786692 , 53790389 , 57371919 , 103473362 , 134339141 , 134339516 , 139108293 , 184812008 , 198938892 , 221678828 , 235284301
TTD Drug ID
D0YX7E
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
References
1 ClinicalTrials.gov (NCT01989884) An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
2 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.